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Abstract
The dentate gyrus is a site of continued neurogenesis in the adult brain. The CA3 region of the hippocampus is the major
projection area from the dentate gyrus. CA3 sends reciprocal projections back to the dentate gyrus. Does this imply that
CA3 exerts some control over neurogenesis? We studied the effects of lesions of CA3 on neurogenesis in the dentate gyrus,
and on the ability of fluoxetine to stimulate mitotic activity in the progenitor cells. Unilateral ibotenic-acid generated lesions
were made in CA3. Four days later there was no change on the number of either BrdU or Ki67-positive progenitor cells in
the dentate gyrus. However, after 15 or 28 days, there was a marked reduction in surviving BrdU-labelled cells on the
lesioned side (but no change in Ki-67+ cells). pCREB or Wnt3a did not co-localise with Ki-67 but with NeuN, a marker of
mature neurons. Lesions had no effect on the basal expression of either pCREB or Wnt3a. Subcutaneous fluoxetine (10 mg/
kg/day) for 14 days increased the number of Ki67+ cells as expected on the control (non-lesioned) side but not on that with
a CA3 lesion. Nevertheless, the expected increase in BDNF, pCREB and Wnt3a still occurred on the lesioned side following
fluoxetine treatment. Fluoxetine has been reported to decrease the number of ‘‘mature’’ calbindin-positive cells in the
dentate gyrus; we found this still occurred on the side of a CA3 lesion. We then showed that the expression GAP-43 was
reduced in the dentate gyrus on the lesioned side, confirming the existence of a synaptic connection between CA3 and the
dentate gyrus. These results show that CA3 has a hitherto unsuspected role in regulating neurogenesis in the dentate gyrus
of the adult rat.
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Introduction
A striking feature of adult neurogenesis in the dentate gyrus of
the hippocampus is the number of factors that can alter its’ rate.
The list includes: exercise, learning, stress, compounds that alter
nitric oxide, excess adrenocortical glucorticoids, and drugs that
regulate serotonin, such as the SSRI (selective serotonin reuptake
inhibitor) fluoxetine.[1,2,3,4,5,6] This list is a mixture of external
agents (such as exercise, or stress), internal responses (such as
glucocorticoids) and potential neural mechanisms (such as
serotonin), and it is not always clear how these relate to one
another, though there is evidence of interactions between them:
for example, glucocorticoids and serotonin [4]. Neither is the site
of action of these agents really understood. It has been assumed
that they act within the gyrus, since this is the site of the progenitor
cells, as well as the surrounding milieu which is presumed, in some
way, to provide a suitable environment not only for neurogenesis
itself, but also for allowing connections of newly formed cells to the
appropriate afferent and efferent sites[7,8].
CA3 is the major efferent site for the neurons of the dentate
gyrus[9]. It is known that both newly-formed cells, as well as dentate-
derived grafts from neonatal animals, send projections to CA3 [10].
What is not known is whether CA3 exerts any reciprocal influence on
neurogenesis in the dentate gyrus. Yet there are clues that it might:
for example, lesions of CA3 result in excess sprouting of mossy fibres
within the dentate gyrus [11,12,13], and there is electrophysiological
evidence for excitatory inputs from CA3 to the dentate granule cells
[14]. There is no evidence on whether or not CA3 has any influence
on the process of neurogenesis within the dentate gyrus, or on the
ability of drugs such as fluoxetine to increase it. Should this occur, it
would add a new dimension to our knowledge of the way that
neurogenesis is controlled from within the hippocampus. It might
also suggest additional sites of action for systemic agents, such as
glucocorticoids, that control neurogenesis [8].
In this paper, we report the effects of small, highly-localised,
unilateral lesions of CA3 on the basal levels of mitosis in the
progenitor cells lining the innermost region of the granule cell
layer of the dentate gyrus, on the survival of newly-formed
neurons, and whether these lesions alter the mitotic response of
progenitor cells to the SSRI fluoxetine. We also explore the effects
these lesions have on the expression of BDNF (Brain derived
neurotrophic factor), pCREB (Phosphorylated cyclic AMP re-
sponse element) and Wnt3a, all known to be concerned in the
regulation of progenitor cell mitosis [15], and on markers of
synapse formation (GAP-43) and neuronal maturation (NeuN,
calbindin) in the dentate gyrus [16,17].
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Lesions were sharply restricted to CA3 area (Figure 1A) and did
not encroach into the neighbouring dentate gyrus. Within the area
of the lesion, there was virtually complete loss of pyramidal cells.
Saline infusions had no discernible effect.
Experiment 1. The effect of unilateral CA3 lesions on
rates of progenitor proliferation
In the first experiment we asked whether a unilateral lesions
of CA3 would alter the number of mitotic progenitor cells in the
dentate gyrus after four days. There were no differences
between lesioned and saline-infused animals in either the
number of BrdU-positive cells (labelled for four days immedi-
ately before the lesion) (repeated measures ANOVA: F=0.14;
p:ns (not significant)) or Ki67-positive ones (mitotic at the time
of sampling, four days after the lesion) (F=6.4, p:ns). The
number of BrdU positive cells in the control animals was
22.763.5 (mean 6 SEM) on the right (saline infused) side
compared to 21.761.2 on the left side, and in lesioned animals
was 21.161.5 on the right (ibotenic acid) ) on the left (non-
lesion) 20.861.6. Ki-67 counts were: in the control animals
20.260.8 (right) and 21.7+1.34 (left); for lesioned animals:
22.6 +1.1 and 20.8 +1.07 (left).
Experiment 2: Effect of CA3 lesions on early-stage
survival of newly-formed neurons in the dentate gyrus
We next examined whether lesions altered the survival of newly-
formed neurons. In this case, there was still no difference in the
number of Ki-67 labelled cells 15 days after a unilateral CA3
lesion (right side; Fig. 1A) compared to the left side (saline infusion)
(F=0.3, p:ns) (Figure 1B). However, there was a highly significant
reduction in the number of BrdU-labelled cells on the lesioned
(right) side (F=6.4, p=0.03) (Figure 1C), suggesting decreased
survival of progenitor cells that were mitotic at the time of the
lesion, and thus forming new neurons.
We wanted to determine whether pCREB or Wnt3a co-
localised with either mature neurons or progenitor cells. Double-
staining showed that Ki-67 did not co-localise with either pCREB
or Wnt3a. However, both co-localised with NeuN, a marker of
mature neurons (Figure 1D).
Experiment 3. Effect of CA3 lesions on survival of new
neurons after 28 days
Since newly-formed neurons take around 28 days to mature,
the next experimentexamined rats given pre-lesion BrdU and
sampled after this interval. Pairwise comparison between
i n f u s e d( r i g h t )a n dn o n - i n f u s e d( l e f t )s i d e ss h o w e dt h a tt h e r e
were fewer BrdU-stained cells on the ibotenic acid-infused
Figure 1. (A) Cresyl violet staining of the CA3 lesion following ibotenic acid infusions. (B) The effect of CA3 lesion on the newly formed
neurons BrdU and the mitosis rates Ki-67 (C) of progenitor cells in the dentate gyrus. Mean number per section after 14 days, compared to controls
(saline infusion). Values are mean 6SEM. **p,0.01, compared to control. (D) Immunofluorescent Co-localisation of NeuN stained in green, pCREB
(left) and Wnt3a stained in red (right) in saline treated animals. Double labelling for NeuN/pCREB and NeuN/Wnt3a appears orange, Ki67 staining is
green. Bar represents a distance of 100 mm and 50 mm.
doi:10.1371/journal.pone.0017562.g001
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animals (t=1.9, p:ns) (Figure 2A). There was no change in those
labelled with Ki-67 (F=0.2, p:ns) (Figure 2B). A repeated
measures ANOVA including both time points showed a highly
significant effect of lesioned vs non-lesioned side (F=7.6,
p=0.012) but no effect of time (15 or 28 days) for BrdU
labelling (p:ns). This was confirmed by double-staining cells with
BrdU and NeuN, which showed that it was these cells that had
decreased (F=5.6, p=0.05 (Figure 2C). There was no change
in the expression of pCREB or Wnt3a in both experiment 2 and
3( T a b l e1 . )
Experiment 4. Effect of CA3 lesions on the ability of
fluoxetine to stimulate progenitor cell mitosis in the
dentate gyrus
Both previous experiments had shown that basal levels of
mitosis in the progenitor cells were not altered by CA3 lesions,
although subsequent survival of these cells were highly compro-
mised. There is evidence that the requirements for increasing
mitosis may differ from basal conditions. For example, blocking
trkB receptors has no effect on basal rates, but prevents fluoxetine
from increasing them [15]. So we asked whether fluoxetine
retained its ability to stimulate progenitor mitosis.
Rats with unilateral CA3 lesions and implanted with osmotic
minipumps releasing fluoxetine (10 mg/kg/day) failed to show the
expected increase in Ki-67 labelled cells on the lesioned side after
14 days treatment, compared to the unlesioned side (F=11.7,
p=0.009) (Figure 3B). Although there seemed to be a similar
decrease in BrdU-labelled cells on the lesioned side in fluoxetine-
treated animals, this was not significant (F=2.7, p:ns)(Figure 3A)
Since fluoxetine no longer stimulated progenitor mitosis after a
CA3 lesion, we wanted to know whether we could determine more
precisely how this happened. It is known that BDNF is increased
by fluoxetine [18], and that this seems essential for increased
progenitor mitosis [15]. Double-staining showed that a number of
NeuN-expressing cells also stained for BDNF. CA3 lesions
themselves had no effect on BDNF in the dentate gyrus after 14
days in experiment 4. Fluoxetine, as expected, increased BDNF
expression following 14 days fluoxetine treatment in both control-
lesioned rats and on the unlesioned side in those with a CA3 lesion
(F=23.2, p,0.001). However, it also increased BDNF on the
lesioned side, and there was no difference between the two sides
(F=0.67, p:ns) (Figure 3C).
Since increases in both pCREB and Wnt3a expression in the
dentate gyrus accompany fluoxetine-stimulated progenitor mitosis,
we next asked whether this still occurred after a CA3 lesion As
expected, fluoxetine treatment for 14 days increased the
Figure 2. The effect of CA3 lesion on (A) the newly formed neurons staining for BrdU and (B) the number of Ki-67-positive
progenitor cells in the dentate gyrus. Mean number per section after 28 days, compared to controls (saline infusion). Values are means 6 SEM.
Values are mean 6SEM. **p,0.01, p:ns compared to control. (C) double-stained cells with BrdU and NeuN. Bar represents a distance of 200 mm and
100 mm.
doi:10.1371/journal.pone.0017562.g002
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28 days (Experiment 3) and following treatment with subcutaneous saline or fluoxetine-containing pumps for 14 (Experiment 4), 3
animals/group and 3 sections/animal.
TT
Wnt3a Mean
OD ±SE Left
Wnt3a Mean OD ±SE
Right (lesion)
pCREB Mean OD
±SE Left
pCREB Mean OD
±SE Right (lesion)
Experiment 2
Saline lesion (14 days) 24.2060.55 26.0460.21 29.9760.05 29.0062.1
Ibotenic acid lesion (14 days) 26.1961.55 27.1662.54 29.3360.88 29.3560.69
Experiment 3
Saline lesion (28 days) 27.0960.73 27.2860.53 26.1561.11 26.4860.63
Ibotenic acid lesion (28 days6 26.5960.75 27.5161.33 26.1161.20 26.3061.47
Experiment 4
Saline pumps (14 days) 28.0061.85 27.2461.39 28.9960.89 27.6260.44
Fluoxetine pumps 10
mg/kg/day (14 days)
87.6461.57 87.2161.42 97.4561.50 98.4360.45
doi:10.1371/journal.pone.0017562.t001
Figure 3. The effect of CA3 lesions on (A) the survival of BrdU cells and (B) number of Ki-67+ progenitor cells in the dentate gyrus
after 14 days treatment with either fluoxetine (10 mg/kg/day) or saline subcutaneously (osmotic minipump). Values are means 6
SEM., **p,0.01 compared to control. (C) Immunofluorescent staining of BDNF after the two treatments. Values are mean optical density of
BDNF 6SEM. **p,0.001. Bar represents a distance of 50 mm.
doi:10.1371/journal.pone.0017562.g003
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(pCREB, p,0.001, Wnt3a p,0.001) but there was no difference
between the lesioned and non-lesioned sides (side x lesion; p:ns in
both cases) (Table 1).
Fluoxetine has been reported to decrease the maturation of
newly-formed neurons as defined by their expression of calbindin
[17]. We confirmed that, on the non-lesioned side, fluoxetine
reduced the number of calbindin-positive cells (F=160, p,0.001).
However, this still occurred on the CA3-lesioned side and there
was no difference between them (F=0.14, p:ns) (Figure 4A).
Since there is evidence for projections from CA3 to the dentate
gyrus (see Introduction) we examined the effect of a CA3 lesion on
expression of GAP-43 in the dentate gyrus. There was a marked
reduction by visual inspection of GAP-43 within the granule cells
on the side of a CA3 lesion compared to the non-lesioned side
(Figure 4B).
Discussion
This paper shows that lesions of the hippocampal CA3 have
major effects on neurogenesis in the dentate gyrus. This has never
been reported before. Since we have not explored the effects of
lesions in other CA fields, we cannot be sure at this stage that these
results are specific to CA3, though, because of the particular
relation between this field and the dentate gyrus, it seems likely
that they will prove to be so. Our first finding was that basal levels
of progenitor cell mitosis were not altered by a CA3 lesion, but the
dentate gyrus was seemingly unable to respond to a well-
established treatment - fluoxetine - that increases it [4]. Since
effects on basal or stimulated rates of mitosis may differ (eg a
flattened corticoid rhythm: [4]), it is important to define ‘basal’
levels. This is always problematic, particularly in the case of
hippocampal neurogenesis which is so sensitive to a variety of
environmental influences (see Introduction). In particular, pertur-
bations of adrenocortical activity can easily alter rates of
neurogenesis [19,20,21]. However, the rats we used were well-
accustomed to their standardised housing and social environment,
so could be credibly classified as being in a ‘basal’ state. Both our
first experiment, in which we measured Ki-67-labelled cells, and
the fourth one, where we gave BrdU up to 24 hours before
sacrifice, confirmed that CA3 lesions had no effect on basal levels
of progenitor mitosis.
However, we found that fluoxetine was no longer able to
increase the mitotoic rate of progenitor cells in the dentate gyrus in
the presence of a CA3 lesion. Reports on the ability of this drug to
stimulate mitosis have differed. Some confirm a positive result
[22,23] but others do not [24,25]. Emerging evidence suggests that
route of administration (oral, subcutaneous injection, osmotic
minipump) is important: only minipump infusions have reliably
increased mitosis rates. The solvent used is another factor:
propylene glycol itself increases mitosis rates (our unpublised data).
Our finding that there are differential effects of a treatment
(fluoxetine) on stimulated progenitor cell mitosis, but not basal
levels, echoes previous reports. We find, for example, that blocking
trkB receptors with the drug K252a has no effect on basal mitosis
rates, but prevents the increase which otherwise follows treatment
with fluoxetine [15]. This suggests that particular mechanisms are
involved in raising mitosis rates in response to modifications in
Figure 4. The number of calbindin-positive cells in the dentate gyrus after. (A) CA3 lesiona combined with either fluoxetine (10 mg/kg/day)
or saline subcutaneously (minipumps for 14 days). (B) Immunofluorescent staining of GAP-43 on the lesion edside compared to the non lesioned side.
Bar represents a distance of 200 mm.
doi:10.1371/journal.pone.0017562.g004
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reduced: treatment with excess corticoids suppresses mitosis to well
below the basal rate [26]. Previous results have also shown that
BDNF is involved in the response to progenitor cell to fluoxetine
[27,28]. We therefore sought to determine whether the expected
increase in BDNF content in the dentate gyrus following fluoxetine
treatment might have been prevented by CA3 lesions. But this was
not the case. The anticipated increase in BDNF following changed
serotonin still occurred. Since intracerebroventricular infusions of
BDNF increase progenitor mitosis in the dentate gyrus [29], one
question raised by this result was why this did not occur despite
raised BDNF.
We therefore examined the expression of pCREB and Wnt3a.
We have previously shown that both increase in the dentate gyrus
after fluoxetine treatment, together with BDNF [15]. However,
the canonical intracellular pathway responding to Wnt3a (b-
catenin) is distinct from that for BDNF, which operates via
pCREB - though the relationship between BDNF and pCREB is
two-way and complex [30]). It was possible that either or both of
these intracellular components might have been affected by CA3
lesions, and thus could explain why fluoxetine no longer activated
progenitor cell mitosis. But we found that the expected increase in
both pCREB and Wnt3a expression still occurred in the dentate
gyrus following fluoxetine treatment on the side of a CA3 lesion,
even though no change in progenitor cell mitosis from basal levels
was observed. To test whether another known effect of fluoxetine
was sensitive to this lesion, we examined the expression of
calbindin. It has been reported that fluoxetine can reduce the
expression of calbindin in the dentate gyrus, an effect which is held
to be evidence for a ‘de-maturation’ of newly-formed neurons,
since calbindin is typically expressed by mature ones [17]. We
confirmed that rats treated with fluoxetine showed reduced levels
of calbindin expression; but this also occurred on the side of a CA3
lesion. It appear that the inhibitory effects of a CA3 lesion on the
efficacy of fluoxetine (and hence, it would seem, serotonin) is not a
generalised one, and does not necessarily apply to all its actions on
the dentate gyrus. However, our findings do show that activation
of a range of cellular events known to be associated with, and
possibly responsible for, accelerating the rate of mitosis on the
progenitor cells of the dentate gyrus still occur after a CA3 lesion;
nevertheless, the expected increase no longer occurs.
In order to demonstrate directly a connection between CA3 and
the dentate gyrus we stained the latter for GAP-43, a synaptic
marker [31]. We found that GAP-43 was depleted in lesioned
animals. This supports the evidence already cited of a connection
between the two structures, though ascribing these synapses to a
projection from CA3 is only a reasonable assumption. Electro-
physiological recordings have shown that this connection is largely
excitatory to the basket cells in the dentate gyrus, which
themselves inhibit the granule cells, and hence mossy fibre output
back to CA3 [14]. We did not specifically examine mossy fibres
within the dentate gyrus, but there are reports that CA3 lesions
induce aberrant sprouting of these fibres [12,32]. Whether either
of these events is responsible for the findings reported here remains
an open question. However, since the expected alterations in
BDNF, pCREB and Wnt3a still occurred in CA3-lesioned
animals, it does seem that this serotonin-acting drug acts on the
dentate gyrus itself, rather than primarily on CA3, which may
have a permissive role. Whether this applies to other regulatory
agents, such as glucocorticoids, is still not determined.
Our finding that there is a marked decrease in survival of newly-
born neurons after CA3 lesions is more easily explained. Since
these cells ordinarily project to CA3, the loss of this terminal area
might be expected to reduce their ability to make connections and
thus survive. Survival even under normal conditions is only around
50% [33], so it is not surprising that removal of their target area
further compromises these cells. Our results suggest that one
mechanism for the failure of so many new neurons to survive even
under basal conditions may be competition for efferent contact
with receptor neurons in CA3.
The results reported here open a new window on the control of
neurogenesis in the adult hippocampus. They suggest that
regulation does not reside entirely within the dentate gyrus, the
site of neurogenesis, but that the projection area of newly-formed
neurons, CA3, exerts a hitherto unknown but potent reciprocal
influence over the activation of neurogenesis in the adult brain at
least by one class of anti-depressants. Whether this applies to
others is still to be determined.
Materials and Methods
Animals
All procedures were carried out under Home Office (UK)
licence (PPL80/1966). Male Sprague-Dawley rats (Harlan, Oxon,
UK) were used, weighing 200–250 grams at the start of the
experiment. Rats were housed individually in a controlled
environment. Ambient temperature was maintained at 21uC and
humidity at 55% with ad libitum access to food and tap water.
Animals were kept in a reversed 12-h light: 12-h dark cycle (lights
off at 10.00 hours).
Experimental design
Experiment 1. In the first experiment we asked whether a
unilateral lesions of CA3 would alter the mitosis rates of the
progenitor cells in the dentate gyrus in the short term. Two groups
of rats (n=3 per group) received four BrdU injection 50 mg/kg/
day intraperitoneally for four days. On day 5 a unilateral lesion
(ibotenic acid, see above) was made or an equivalent volume of
saline was infused into CA3. The animals were killed on day 9.
Experiment 2. The next experiment tested whether CA3
lesions altered the survival of early-stage newly-formed neurons.
Animals (n=6 per group) received a single BrdU injection
(200 mg/kg) the day before either CA3 lesions or control
infusions were made as in the previous experiment. However,
they were killed 15 days after the lesion.
Experiment 3. Since progenitor cells take around 28 days to
fully mature, the third experiment examined rats which had been
given BrdU (50 mg/kg/day) for 4 days, then received either CA3
lesions or control infusions unilaterally as above, and sampled after
28 days. (n=6 per group)
Experiment 4. This examined the ability of progenitor cells
in rats with CA3 lesions to respond to fluoxetine (Fluoxetine
hydrochloride:Sigma Dorset,UK, catalogue number F-132). Rats
(n=5 per group) received CA3 lesions on day1, and were also
implanted with subcutaneous osmotic minipumps in the posterior
upper thorax (model 2ML2 the rate of flow is 5 ml/hr for 14 days)
(Charles River, Margate, UK, catalogue number 2ML2) filled
either with fluoxetine (releasing 10 mg/kg/day dissolved directly
in saline under running hot tap water or saline, therefore for
animals weighing 250 gm they would receive 46.6 mg of
fluoxetine in one osmotic minipump,. They also received four sc
injections of BrdU (50 mg/kg/day) for four days starting on day
10. They were killed 14 days later.
Ibotenic acid lesions
Rats were anesthetised using isofluorane, oxygen and NO and
placed securely into a stereotaxic frame (David Kopt instru-
ments,Tujunga,CA,USA). The dorsal surface of the skull was
CA3 Lesions and Neurogenesis
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17562exposed, a hole was drilled and a cannula inserted A 5 ml
Hamilton syringe fitted with a 30-gauge cannula and filled with
ibotenic acid solution (Sigma,Dorset,UK,catalogue number
12765) (10 mg/ml;0.2 ml/site) was inserted using the following
coordinates: 2.7–4.7 mm caudal to bregma (AP), 4.1 mm right
from the mid line (L) and 4.5 mm from the cortical surface (V)
([34]. Infusions were made at three AP sites 1 mm apart. The flow
rate was 0.6 ml/3 min for each site using an auto injector device
(Cole-Palmer, London UK). The cannula was left in place for
2 min and slowly retracted thereafter. Control rats were subjected
to the same procedure except that saline was injected.
Brain fixation and histology
Rats were deeply anesthetised with a terminal dose of
pentobarbital sodium and perfused transcardially with 0.1 M
phosphate-buffered saline (PBS, pH 7.4), followed by 4%
paraformaldehyde in PB. Brains were removed and post-fixed in
the same fixative for 4 hours then transferred to 30% sucrose in
PBS overnight.
Serial coronal sections (40 mm) were cut with a freezing
microtome through the entire length of the dorsal hippocampus
(from22.80 to 24.52 mm behind bregma), placed into a well of
anti-freeze (1:1:2 glycerol:ethylene glycol: 0.1 PBS) and kept at
220uC until use.
Quantification
Proliferating cells Ki-67 and BrdU. Slides were rando-
mised and coded prior to quantitative analysis. Labelled cells on
each side of the brain were counted using a 40X objective; only
cells on the internal border of the subgranular zone of the dentate
gyrus were included. The data shown are the mean number of Ki-
67 or BrdU labelled cells per section from 12 sections (1 in 6) per
animal; starting from 2.80 to 24.52 mm behind bregma.
Analysis of pCREB, Wnt3a, BDNF. Three sections per
animal (1:12 starting between bregma 23.14 mm and 23.30 mm)
were used.;.After staining the images were captured (x10 objective)
using AxioCam digital camera attached to Carl Zeiss microscope
they were then displayed on a computer screen where AxioVision
application software were used they were standardised by setting
the exposure and brightness to a constant value The images were
then saved in JPEG format, and analysed using Image J-64. On
each section 3–4 circles (59.2 mm diameter) 200 mm apart were
drawn on each blade of the dentate gyrus, starting 400 mm from
the hilus, and the OD (optical density) measured in each. Results
are given as mean OD per animal (Table 1).
Calbindin: positive cells were counted on each side of the
dentate gyrus (CA3 lesioned and non lesioned sides) on three
sections per animal in Experiment 4.
Statistical analysis
Within animal comparisons (between lesioned and non-lesioned
sides) were analysed with repeated measures ANOVA. Between
animal comparisons were made by multivariate ANOVA or t-tests,
as appropriate. Homogeneity of variance was checked with
Levene’s test.
Immunohistochemistry
Single Staining. Ki-67: sections were incubated in 0.01 M
citric acid for 40 min at 98uC. They were cooled and washed twice
65 min in KPBS (Potassium phosphate buffer saline).
Endogenous peroxidase activity was quenched with 3% H2O2
solution for 10 min followed two 5 min washes with KPBS. Then
they were incubated with primary antibody (1:100 mouse
monoclonal IgG anti-human Ki-67; Novocastra, Newcastle
Upon Tyne, UK, catalogue number VP-K452) and 1% horse
serum in a humidified chamber at room temperature overnight.
The next day, after two 6 5 min washes with KPBS, they were
incubated with secondary antibody (1:200 biotinylated mouse IgG;
Vector laboratories Ltd, Peterborough UK, catalogue number
6102) for 1 hour at room temperature. After two 5 min washes
with KPBS, they were incubated with Avidin-Biotin-Peroxidase
(Vector laboratories Ltd, Peterborough UK) for a further hour,
followed by two 5 min washes with KPBS. The staining was
visualized using DAB (3,3-diaminobenzidin) tablets (Sigma,
Dorset, UK) for 5 min.
Slides were then counterstained with 10% cresyl violet solution
followed by dehydration through ethanol and Histoclear. They
were cover-slipped with DPX (Distyrene-xylene;BDH,Leicester-
shire,UK) for light microscopy.
BrdU: sections were mounted on poly-lysin-coated slides (BDH,
UK),dried overnight, incubated in 0.01 M citric acid for 15 min at
97uC, then in 3% H2O2 for 10 min, digested in trypsin (0.025%)
for 10 min, denatured in 2N HCl for 30 min at 37u C, rinsed, and
incubated in mouse monoclonal antibody raised against BrdU
(Novocastra Newcastle Upon Tyne, UK, catalogue number VP-
B209) 1:200 in 0.3% triton,1% normal horse serum) overnight at
room temperature. The slides were rinsed and taken through a
mouse IgG ABC kit procedure (Vector), rinsed again and reacted
for 5 min with DAB tablets (Sigma), rinsed, dehydrated and cover
slipped under DPX as above.
Fluorescent Single & Double staining. pCREB and
Wnt3a single staining: Free floating sections from each
animal (1 in 12) were incubated in rabbit anti-pCREB (Cell
Signaling, Hitchen, UK, catalogue number 9198; 1:25 in 0.3%
Triton with 1% goat serum) overnight in a humidified chamber at
room temperature. After two washes with KPBS, sections were
incubated in Alexa Fluor 568 (Invitrogen, Paisley UK, catalogue
number A-11011) goat anti-rabbit (1:200 in 0.5% Triton) for one
hour, washed twice with KPBS, and cover-slipped.
For staining with Wnt3a, sections were incubated in rabbit anti-
Wnt3a (Abcam, Science Park, Cambridge UK, catalogue number
ab-28472; 5 mg/ml in 0.3% Triton with 1% goat serum) overnight
in a humidified chamber at room temperature. The following day,
after two washes with KPBS, they were incubated in Alexa Fluor
568 goat anti-rabbit (1:200 in 0.5% Triton) for one hour, and
washed twice with KPBS.
BDNF: sections were incubated in rabbit anti-BDNF (Santa
Cruz Biotechnology, Wembley, Middlesex, UK, catalogue num-
ber Sc-20981; 1:100 in 0.3% Triton with 1% goat serum)
overnight in a humidified chamber at 4uC. After two washes with
KPBS, the sections were incubated in Alexa Fluor 568 (Invitrogen,
Paisley, UK) goat anti-rabbit (1:500 in 0.3% Triton) for one hour,
washed twice with KPBS, and cover-slipped.
BrdU and NeuN double labelling: Free floating sections
from each animal (1 in 12; between bregma 23.14 mm and
23.30 mm) were washed twice with KPBS for 5 min and then
denatured in 2N HCl for 30 min at 37uC, rinsed and then
incubated for double label in a mixture of mouse anti NeuN
(Millipore, Chandlers Ford, Hants, UK, catalogue number
MAB377) (1:100 in [0.3% Triton in KPBS] with 1% goat serum)
and rat anti-BrdU (Accurate Chemical &Scientific Corporation,
Westbury,USA, catalogue number OBT0030) (1:200 in 0.3%
Triton with 1% goat serum) overnight at 4uC. The next day after
two washes with KPBS, the sections were incubated in a mixture
of Alexa Fluor 568 goat anti rat catalogue number A-11077 [red]
(1:200) and goat anti mouse Alexa Fluor 488 catalogue number
A-11001 [green] 1:200 in 0.3% Triton + 1% goat serum for one
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slipped using a mixture of 50% glycerol and KPBS. Co-localized
cells were coloured orange.
Wnt3a and NeuN or pCREB and NeuN: Free floating
sections were incubated overnight at 4uC in a mixture of rabbit
anti Wnt3a (Abcam, Science Park, Cambridge UK; 5 mg/ml in
0.3% Triton with 1% goat serum) and NeuN (Millipore,
Chandlers Ford, Hants, UK) (1:00 in [0.3% Triton in KPBS]
with 1% goat serum) or a mixture of rabbit anti pCREB and
NeuN as above. The next day after two washes with KPBS, the
sections were incubated in a mixture of Alexa Fluor 568 goat anti
rabbit [red] (1:200) and goat anti mouse Alexa Fluor 488 [green]
1:200 in 0.3% Triton+1% goat serum for one hour, washed twice
with KPBS, mount the sections on slide and cover slipped using a
mixture of 50% glycerol and KPBS. Co-localized cells were
orange.
GAP-43: Free floating sections were incubated with mouse anti
GAP-43 (Millipore, Chandlers Ford, Hants, UK, catalogue
number MAB347 1:400 in 0.3% Triton in KPBS with 1% goat
serum overnight at 4uC. The next day, after two washes with
KPBS, the sections were incubated in goat anti mouse Alexa Fluor
488[green] 1:200 in 0.3% Triton+1% goat serum for one hour,
washed twice with KPBS, mount the sections on slide and cover
slipped using a mixture of 50% glycerol and KPBS.
Calbindin. Free floating sections were incubated with mouse
anti Calbindin (Swant, Bellinzona, Switzerland, catalogue number
300) 1:5000 in 0.4% Triton in KPBS with 1% goat serum
overnight at 4uC. The next day, after two washes with KPBS, the
sections were incubated in goat anti mouse Alexa Fluor 488[green]
1:500 in 0.4% Triton+1% goat serum for one hour, washed twice
with KPBS, mount the sections on slide and cover slipped using a
mixture of 50% glycerol and KPBS.
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